1. Jauregui JJ, Cherian JJ, Pierce TP, Beaver WB, Issa
K, Mont MA. Long-Term Survivorship and Clinical
Outcomes Following Total Knee Arthroplasty. J
Arthroplasty. 2015;30(12):2164-6. doi: 10.1016/j.
arth.2015.05.052.
2. Tiwari V, Meshram P, Park CK, Bansal V, Kim TK. New
mobile-bearing TKA with unique ball and socket postcam
mechanism offers similar function and stability
with better prosthesis fit and gap balancing compared
to an established fixed-bearing prosthesis. Knee Surg
Sports Traumatol Arthrosc. 2019;27(7):2145-2154.
DOI: 10.1007/s00167-019-05430-5
3. Chen X, Ji ZL, Chen YZ. TTD: Therapeutic Target
Database. Nucleic Acids Res. 2002;30(1):412-5. doi:
10.1093/nar/30.1.412.
4. Wang H, Shen B, Zeng Y. Comparison of topical versus
intravenous tranexamic acid in Primary total knee
arthroplasty: a metaanalysis of randomized controlled
and prospective cohort trials. Knee. 2014;21(6):987–
993. doi: 10.1016/j.knee.2014.09.010.
5. Alvarez JC, Santiveri FX, Ramos I, Vela E, Puig L, Escolano
F. Tranexamic acid reduces blood transfusion in total
knee arthroplasty even when a blood conservation
program is applied. Transfusion. 2008;48(3):519-25.
doi: 10.1111/j.1537-2995.2007.01564.x.
6. Drain NP, Gobao VC, Bertolini DM et al. Administration
of Tranexamic Acid Improves Long-Term Outcomes
in Total Knee Arthroplasty. J Arthroplasty.
2020;35(6S):S201-S206. doi: 10.1016/j.arth.2020.
02.047.
7. Kim TK, Chang CB, Koh IJ. Practical issues for the
use of tranexamic acid in total knee arthroplasty:
a systematic review. Knee Surg Sports Traumatol
Arthrosc. 2014;22(8):1849-58. doi: 10.1007/s00167-
013-2487-y.
8. Fillingham YA, Ramkumar DB, Jevsevar DS, et al.
Tranexamic acid in total joint arthroplasty: the
endorsed clinical practice guides of the American
Association of Hip and Knee Surgeons, American
Society of Regional Anesthesia and Pain Medicine,
American Academy of Orthopaedic Surgeons, Hip
Society, and Knee Society. Reg Anesth Pain Med.
2019;44(1):7-11. doi: 10.1136/rapm-2018-000024.
9. Li J, Liu R, Rai S, Ze R, Tang X, Hong P. Intra-articular
vs. intravenous administration: a meta-analysis of
tranexamic acid in primary total knee arthroplasty.
J Orthop Surg Res. 2020;15(1):581. doi: 10.1186/
s13018-020-02119-1.
10. Sun Q, Li J, Chen J, Zheng C, Liu C, Jia Y. Comparison of
intravenous, topical or combined routes of tranexamic acid administration in patients undergoing total knee
and hip arthroplasty: a meta-analysis of randomised
controlled trials. BMJ Open. 2019;28;9(1):e024350.
doi: 10.1136/bmjopen-2018-024350.
11. Meshram P, Palanisamy JV, Seo JY, Lee JG, Kim
TK. Combined Intravenous and Intraarticular
Tranexamic Acid Does Not Offer Additional Benefit
Compared with Intraarticular Use Alone in Bilateral
TKA: A Randomized Controlled Trial. Clin Orthop
Relat Res. 2020;478(1):45-54. doi: 10.1097/
CORR.0000000000000942
12. Meunier A, Petersson A, Good L, Berlin G. Validation
of a haemoglobin dilution method for estimation
of blood loss. Vox Sang. 2008;95:120–124. doi:
10.1111/j.1423-0410.2008.01071.x.
13. Roos EM, Toksvig-Larsen S. Knee injury and
Osteoarthritis Outcome Score (KOOS) - validation
and comparison to the WOMAC in total knee
replacement. Health Qual Life Outcomes. 2003;1:17.
doi: 10.1186/1477-7525-1-17.
14. EQ-5D instruments. Available at: https://euroqol.
org/eq-5d-instruments/eq-5d-5l-about/ Assessed
on Apr 7, 2022
15. Maniar RN, Kumar G, Singhi T, Nayak RM, Maniar PR.
Most effective regimen of tranexamic acid in knee
arthroplasty: a prospective randomized controlled
study in 240 patients. Clin Orthop Relat Res.
2012;470(9):2605-2612. doi: 10.1007/s11999-012-
2310-y.
16. Sample Size Calculator, DSS research 2014. Available
at https://www.dssresearch.com/KnowledgeCenter/
toolkitcalculatorsstatisticalpowercalculators.aspx.
Assessed 2 Jan, 2022
17. Lee SY, Chong S, Balasubramanian D, Na YG, Kim
TK. What is the ideal route of administration of
tranexamic acid in TKA? A randomized controlled
trial. Clin Orthop Relat Res. 2017;475:1987-1996. doi:
10.1007/s11999-017-5311-z
18. Lin SY, Chen CH, Fu YC, Huang PJ, Chang JK, Huang
HT. The efficacy of combined use of intraarticular
and intravenous tranexamic acid on reducing blood
loss and transfusion rate in total knee arthroplasty.
J Arthroplasty. 2015;30(5):776-80. doi: 10.1016/j.
arth.2014.12.001.
19. Dorji Y, Singh CM, Mishra AK, Sad D. Efficacy of
combined use of intravenous and intra-articular
versus intra-articular tranexemic acid in blood loss
in primary total knee arthroplasty: A randomized
controlled study. JAJS. 2021;8(2) 134-138. https://
doi.org/10.1016/j.jajs.2020.12.006
20. Zhang YM, Yang B, Sun XD, Zhang Z. Combined
intravenous and intra-articular tranexamic acid
administration in total knee arthroplasty for
preventing blood loss and hyperfibrinolysis: A
randomized controlled trial. Medicine (Baltimore).
2019;98(7):e14458. doi:10.1097/MD.00000
00000014458.
21. Fillingham YA, Ramkumar DB, Jevsevar DS, et
al. The Safety of Tranexamic Acid in Total Joint
Arthroplasty: A Direct Meta-Analysis. J Arthroplasty.
2018;33(10):3070-3082.e1. doi: 10.1016/j.arth.
2018.03.031.